TECH · Nasdaq · CIK 0000842023

BIO-TECHNE Corp

BIO-TECHNE Corp’s most recent SEC filing in our snapshot is a Form 4 filed on Sep 30, 2026. In fiscal 2026 (year ended Jun 30, 2026) it reported revenue of $1.2B and net income of $181.9M, according to its XBRL data on EDGAR. Its EDGAR record lists 42 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$1.2B
Net income, FY2026
$181.9M
Form 4 filings on record, past 12 months
42

Company overview

Legal name (as filed)
BIO-TECHNE Corp
Ticker
TECH
SEC Central Index Key (CIK)
0000842023
Business address
MINNEAPOLIS, MN
State or country of incorporation
MN
Fiscal year ends
June 30
SEC filer category
Large accelerated filer
Position in SEC ticker list
#835 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BIO-TECHNE Corp’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.1BFY2022$1.1BFY2023$1.2BFY2024$1.2BFY2025$1.2BFY2026
Net income
$272.1MFY2022$285.3MFY2023$168.1MFY2024$73.4MFY2025$181.9MFY2026
TECH annual results
ItemFY2022
ended Jun 30, 2022		FY2023
ended Jun 30, 2023		FY2024
ended Jun 30, 2024		FY2025
ended Jun 30, 2025		FY2026
ended Jun 30, 2026
Revenue$1.1B$1.1B$1.2B$1.2B$1.2B
Net income$272.1M$285.3M$168.1M$73.4M$181.9M
Diluted EPS$1.66$1.76$1.05$0.46$1.16
Total assets$2.3B$2.6B$2.7B$2.6B$2.6B
Cash and equivalents$172.6M$180.6M$151.8M$162.2M$264.7M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

TECH latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Aug 24, 202610-KAnnual report· period Jun 30, 2026Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Sep 23, 20268-KShareholder vote results; Regulation FD disclosure· period Sep 23, 2026Document · Index
Sep 19, 2025DEF 14ADEFINITIVE PROXY STATEMENT· period Oct 30, 2025Document · Index

Recent SEC filings

The 40 newest documents filed by or about BIO-TECHNE Corp, by form type:

4 ×22DEFA14A ×68-K ×5144 ×110-K ×1DEFM14A ×1PREM14A ×1SCHEDULE 13G/A ×1SD ×110-Q ×1
TECH recent filings
FiledFormWhat it isOriginal
Sep 30, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Sep 28, 2026Document · Index
Sep 24, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Sep 22, 2026Document · Index
Sep 23, 20268-KShareholder vote results; Regulation FD disclosure· period Sep 23, 2026Document · Index
Sep 14, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Sep 14, 20268-KOther events· period Sep 14, 2026Document · Index
Sep 9, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Sep 2, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Aug 25, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Aug 24, 202610-KAnnual report· period Jun 30, 2026Document · Index
Aug 20, 2026DEFM14ADEFM14ADocument · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 19, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 17, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 18, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Aug 15, 2026Document · Index
Aug 12, 20268-KResults of operations; Other events· period Aug 12, 2026Document · Index
Aug 10, 2026PREM14APREM14A· period Aug 10, 2026Document · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 31, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Jul 29, 2026Document · Index
Jul 30, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Jul 28, 2026Document · Index
Jul 27, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Jul 23, 2026Document · Index
Jul 9, 2026DEFA14ASOLICITING MATERIALDocument · Index
Jun 26, 20268-KMaterial agreement; Director or officer change· period Jun 23, 2026Document · Index
Jun 25, 2026DEFA14ASOLICITING MATERIALDocument · Index
Jun 25, 20268-KRegulation FD disclosure· period Jun 25, 2026Document · Index
Jun 4, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period Jun 2, 2026Document · Index
Jun 1, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 12, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 8, 2026Document · Index
May 8, 2026144Notice of proposed sale of securitiesDocument · Index
May 7, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 5, 2026Document · Index
May 7, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 5, 2026Document · Index
May 7, 20264STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES· period May 5, 2026Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index

Insider filing activity

42 Form 4 filings appear in BIO-TECHNE Corp’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Biological Products, (No Diagnostic Substances)

All 61 companies in Biological Products, (No Diagnostic Substances)· Companies headquartered in Minnesota

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000842023 and XBRL company facts. BIO-TECHNE Corp on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.